logo

For the Inventor, By the Inventor

Paris, France

Jean-Pierre Raynaud

This inventor holds 12 USPTO granted patents. Top assignees: Roussel Uclaf, Pierre Fabre Medicament, Shering Corporation. Active years: 1980-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Pierre Raynaud. Retrieved from https://idiyas.com/inventor/jean-pierre-raynaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 150(Granted Patents)


Company Filing History:

goldMedal10 out of 854 
 
Roussel Uclaf
 patents
silverMedal1 out of 269 
 
Pierre Fabre Medicament
 patents
bronzeMedal1 out of 2 
 
Shering Corporation
 patents
4. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-2003

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6599540 - Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer (2003-07-29),
2. 5712251 - Treatment method (1998-01-27),
3. 5688769 - Treatment method (1997-11-18),
4. 5389613 - Method of treating prostate adenocarcinoma, prostate benign hypertrophia (1995-02-14),
5. 5189021 - Method of treating precocious puberty (1993-02-23),
6. 4981842 - Method of treating hormonal dependent mammary tumors in female mammals (1991-01-01),
7. 4851386 - Method of treating precocious puberty (1989-07-25),
8. 4745102 - Novel treatment method (1988-05-17),
9. 4743589 - Treatment of endometriosis (1988-05-10),
10. 4728640 - Treatment of dysmenorrhea (1988-03-01),
11. 4472382 - Treatment method (1984-09-18),
12. 4191697 - Novel steroids (1980-03-04),

Title: The Innovative Contributions of Jean-Pierre Raynaud

Introduction

Jean-Pierre Raynaud is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of prostate cancer. With a total of 12 patents to his name, Raynaud's work has had a profound impact on medical research and treatment methodologies.

Latest Patents

Among his latest patents is the innovative use of a Serenoa repens extract for the production of a medicament aimed at treating prostate cancer. This invention involves a lipido-sterolic extract that can be administered either in isolation or in conjunction with prostatectomy, radiotherapy, and/or hormonotherapy. The goal is to prevent and treat prostate cancer effectively. Another significant patent details a method of treating prostate cancer in warm-blooded animals, which includes administering an effective amount of a specific peptide and an anti-androgen.

Career Highlights

Throughout his career, Jean-Pierre Raynaud has worked with prominent companies such as Roussel Uclaf and Pierre Fabre Medicament. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Raynaud has collaborated with esteemed professionals in his field, including Fernand Labrie and Pierre Fabre. These partnerships have further enhanced his research and development efforts, leading to groundbreaking inventions.

Conclusion

Jean-Pierre Raynaud's contributions to medical innovation, particularly in the treatment of prostate cancer, highlight his importance as an inventor. His patents and collaborations reflect a commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…